Registry Study for Radiation Therapy Outcomes

September 2, 2025 updated by: Proton Collaborative Group

Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

40000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • Arizona
      • Scottsdale, Arizona, United States, 85259-5499
        • Recruiting
        • Mayo Clinic
        • Contact:
          • Clinical Trials Office - All Mayo Clinic Locations
          • Phone Number: 855-776-0015 (toll free)
    • Arkansas
      • Little Rock, Arkansas, United States, 72205
        • Recruiting
        • Proton Center of Arkansas
        • Contact:
        • Principal Investigator:
          • Leslie Harrell, MD
    • California
      • San Diego, California, United States, 92121
        • Recruiting
        • California Protons Cancer Therapy Center
        • Contact:
        • Principal Investigator:
          • James Urbanic, MD
    • Florida
      • Delray Beach, Florida, United States, 33484
        • Recruiting
        • South Florida Proton Therapy Institute
        • Principal Investigator:
          • James Snider, MD
        • Contact:
      • Jacksonville, Florida, United States, 32223
        • Recruiting
        • Ackerman Cancer Center
        • Principal Investigator:
          • Ryan Perkins, MD
        • Contact:
      • Miami, Florida, United States, 33176
        • Recruiting
        • Miami Cancer Institute
        • Contact:
        • Principal Investigator:
          • Michael Chuong, MD
      • Miami, Florida, United States, 33125
        • Recruiting
        • Dwoskin Proton Therapy Center
        • Principal Investigator:
          • Matthew Abramowitz, MD
        • Contact:
      • Orlando, Florida, United States, 32806
        • Recruiting
        • Orlando Health Cancer Institute
        • Contact:
        • Principal Investigator:
          • Naren Ramakrishna, MD, Ph. D
    • Georgia
      • Atlanta, Georgia, United States, 30308
        • Recruiting
        • Emory Proton Therapy Center
        • Contact:
        • Principal Investigator:
          • Mark McDonald, MD
    • Illinois
      • Peoria, Illinois, United States, 61603
        • Recruiting
        • OSF HealthCare Cancer Institute
        • Contact:
        • Principal Investigator:
          • Timothy Smile, MD
      • Warrenville, Illinois, United States, 60555
        • Recruiting
        • Northwestern Medicine Chicago Proton Center
        • Contact:
        • Principal Investigator:
          • Arpi Thukral, MD
    • Kansas
      • Kansas City, Kansas, United States, 66160
        • Recruiting
        • University of Kansas Proton Therapy Center
        • Contact:
        • Principal Investigator:
          • Ronny Rotondo, MD
      • Overland Park, Kansas, United States, 66207
        • Recruiting
        • Kansas City Proton Institute
        • Contact:
        • Principal Investigator:
          • James Coster, MD
    • Louisiana
      • Shreveport, Louisiana, United States, 71103
        • Recruiting
        • Willis-Knighton Cancer and Proton Therapy Center
        • Contact:
        • Principal Investigator:
          • Lane Rosen, MD
    • Maryland
      • Baltimore, Maryland, United States, 21201
        • Recruiting
        • Maryland Proton Treatment Center
        • Principal Investigator:
          • Mark Mishra, MD
        • Contact:
    • Michigan
      • Flint, Michigan, United States, 48532
        • Recruiting
        • McLaren Proton Therapy Center
        • Contact:
        • Principal Investigator:
          • Brian Yeh, MD
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Recruiting
        • Washington University in St. Louis
        • Contact:
        • Principal Investigator:
          • Stephanie Perkins, MD
      • St Louis, Missouri, United States, 63141
        • Recruiting
        • Mercy David C. Pratt Cancer Center
        • Contact:
        • Principal Investigator:
          • Amit Roy, MD
    • New Jersey
      • Somerset, New Jersey, United States, 08873
        • Recruiting
        • ProCure Proton Therapy Center
        • Contact:
        • Principal Investigator:
          • Henry Tsai, MD
    • New York
      • New York, New York, United States, 10035
        • Recruiting
        • New York Proton Center
        • Principal Investigator:
          • Charles Simone, MD, FACRO
        • Contact:
    • North Carolina
      • Charlotte, North Carolina, United States, 28204
        • Recruiting
        • Atrium Health Levine Cancer Proton & Advanced Radiation Center
        • Contact:
        • Principal Investigator:
          • Roshan Prabhu, MD
    • Ohio
      • Cincinnati, Ohio, United States, 45044
        • Recruiting
        • University of Cincinnati Medical Center
        • Contact:
        • Principal Investigator:
          • Luke Pater, MD
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73142
        • Recruiting
        • Oklahoma Proton Center
        • Principal Investigator:
          • John Chang, MD
        • Contact:
    • Tennessee
      • Franklin, Tennessee, United States, 37067
        • Recruiting
        • Tennessee Oncology Proton Center
        • Contact:
        • Principal Investigator:
          • James Gray, MD
      • Knoxville, Tennessee, United States, 37909
        • Recruiting
        • Thompson Proton Center
        • Principal Investigator:
          • Ryan Grover, MD
        • Contact:
    • Texas
      • Irving, Texas, United States, 75063
        • Recruiting
        • Texas Center for Proton Therapy
        • Contact:
        • Principal Investigator:
          • Andrew Lee, MD
    • Virginia
      • Fairfax, Virginia, United States, 22031
        • Recruiting
        • Inova Schar Cancer Institute
        • Principal Investigator:
          • Gopal Bajaj, MD
        • Contact:
      • Hampton, Virginia, United States, 23666
        • Recruiting
        • Hampton University Proton Therapy Institute
        • Contact:
        • Principal Investigator:
          • Christopher Sinesi, MD
    • Washington
      • Seattle, Washington, United States, 98195-6043
        • Recruiting
        • University of Washington
        • Contact:
          • Erica Peters, CCRC, CPM
          • Phone Number: 206-598-7188
          • Email: etucker@uw.edu
        • Principal Investigator:
          • Annemarie Shepherd, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Radiation Oncology patients

Description

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Define outcomes for patients treated at participating institutions
Time Frame: PRN
PRN

Secondary Outcome Measures

Outcome Measure
Time Frame
Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures
Time Frame: Annually PRN
Annually PRN
Improve patient care by an adequate understanding of the results and patient population at participating institutions
Time Frame: Reviewed Annually PRN
Reviewed Annually PRN

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Proton Collaborative Group

Investigators

  • Study Chair: Carlos Vargas, MD, Proton Collaborative Group

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2009

Primary Completion (Estimated)

June 1, 2039

Study Registration Dates

First Submitted

December 6, 2010

First Submitted That Met QC Criteria

December 6, 2010

First Posted (Estimated)

December 7, 2010

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REG001-09

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasms

Clinical Trials on Proton Therapy, Photon Therapy, SRS, Brachytherapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe